2024

• Bawden, E., Wagner, T., Schröder, J., Effern, M., Hinze, D., Newland, L., Attrill, G., Lee, A., Engel, S., Freestone, D., Ferguson, A., Edwards, J., Ferguson, P., Scolyer, R., Wilmott, J., Palendira, M., et al (2024). CD4+ T cell immunity against cutaneous melanoma encompasses multifaceted MHC II–dependent responses. Science Immunology, 9(91). [More Information]
• Menzies, A., Emmett, L., Kapoor, R., Rawson, R., Stretch, J., Thompson, J., Spillane, A., Rizos, H., Scolyer, R., Long, G., Lo, S., Saw, R., Gonzalez, M., Ch'ng, S., Nieweg, O., Shannon, K., Ferguson, P., et al (2024). Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma. Annals of Oncology. [More Information]
• Chan, S., Guitera, P., Ferguson, P., El Sharouni, M., Teh, R., Scolyer, R., Glanz, A. (2024). Predictors of malignancy in melanocytic lesions presenting as new lesions compared to baseline total body photography: A case-control study. Journal of the European Academy of Dermatology and Venereology. [More Information]
• Ho, G., Collgros Totosaus, H., Sinz, C., Melhoranse-Gouveia, B., Gallo, B., Chew, C., Ip, K., Koutsis, J., Lo, S., Schwartz-Aldea, R., Ferguson, P., Martin, L., Smith, A., Cust, A., Guitera, P., et al (2024). Remote cutaneous confocal microscopy: A multicentric prospective study evaluating diagnostic accuracy for melanoma and keratinocyte carcinoma in tertiary settings. Journal Of The American Academy Of Dermatology. [More Information]
• Bai, X., Attrill, G., Gide, T., Ferguson, P., Nahar, K., Shang, P., Vergara Correa, I., Palendira, M., Esteves Domingues Pires da Silva, I., Carlino, M., Menzies, A., Long, G., Scolyer, R., Wilmott, J., Quek, C. (2024). Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma. Nature Communications, 15(1), 3014. [More Information]

2023

• Wilmott, J., Tawbi, H., Engh, J., Amankulor, N., Shivalingam, B., Banerjee, H., Vergara Correa, I., Lee, H., Johansson, P., Ferguson, P., Scolyer, R., Long, G., et al (2023). Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases. Clinical Cancer Research, 29(3), 521-531. [More Information]
• Melhoranse Gouveia, B., Carlos, G., Wadell, A., Sinz, C., Ahmed, T., Lo, S., Rawson, R., Ferguson, P., Scolyer, R., Guitera, P. (2023). In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case–control study. Journal of the European Academy of Dermatology and Venereology, 37(7), 1293-1301. [More Information]
• Maher, N., Prosser, N., Aivazian, K., Colebatch, A., Ferguson, P., Karim, R., McKenzie, C., Rawson, R., Lo, S., Scolyer, R. (2023). Inter-rater concordance of basal cell carcinoma subtypes: influences on reporting format and opportunities for further classification modifications. Pathology, 55(6), 800-805. [More Information]
• Orlow, I., Sadeghi, K., Edmiston, S., Kenney, J., Lezcano, C., Wilmott, J., Cust, A., Scolyer, R., Mann, G., Lee, T., Burke, H., Jakrot, V., Shang, P., Ferguson, P., et al (2023). InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma. PloS One, 18(2023-04-04 00:00:00). [More Information]
• McClintock, G., Goolam, A., Perera, D., Downey, R., Leslie, S., Grimison, P., Woo, H., Ferguson, P., Ahmadi, N. (2023). Robotic-assisted retroperitoneal lymph node dissection for stage II testicular cancer. Asian Journal of Urology. [More Information]

2022

• Regio Pereira, A., Guitera, P., Ferguson, P., Ch’ng, S., Hirata, S. (2022). Complex melanoma of the scalp: Diagnosis and management aided by confocal microscopy. Australasian Journal of Dermatology, 63(1), 105-109. [More Information]
• Colebatch, A., Adhikari, C., Diefenbach, R., Rawson, R., Ferguson, P., Rizos, H., Long, G., McCarthy, S., Thompson, J., Wilmott, J., Scolyer, R. (2022). Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi. American Journal of Surgical Pathology, 46(8), 1048-1059. [More Information]
• Semsarian, C., Ma, T., Nickel, B., Scolyer, R., Ferguson, P., Soyer, H., Parker, L., Barratt, A., Thompson, J., Bell, K. (2022). Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? British Journal of Dermatology, 186(6), 1030-1032. [More Information]

2021

• Gide, T., Esteves Domingues Pires da Silva, I., Quek, C., Ferguson, P., Batten, M., Shang, P., Ahmed, T., Menzies, A., Carlino, M., Saw, R., Thompson, J., Scolyer, R., Long, G., Wilmott, J. (2021). Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets. Cancers, 13(13), 3186-1-3186-16. [More Information]
• Gómez-Martín, I., Collgros, H., Ferguson, P., Barreiro, A., Guitera, P., Andrades-López, E., Puig, S., Pujol, R., Barranco, C., Alòs, L., et al (2021). Diagnostic accuracy of pigmented labial macules by in vivo reflectance confocal microscopy and correlation among techniques. Journal Of The American Academy Of Dermatology, 85(5), 1151-1160. [More Information]
• Gibson, M., Scolyer, R., Soyer, H., Ferguson, P., McGeechan, K., Irwig, L., Bell, K. (2021). Estimating the potential impact of interventions to reduce over-calling and under-calling of melanoma. Journal of the European Academy of Dermatology and Venereology, 35(7), 1519-1527. [More Information]
• Gherardin, N., Waldeck, K., Caneborg, A., Martelotto, L., Balachander, S., Zethoven, M., Petrone, P., Pattison, A., Wilmott, J., Quiñones-Parra, S., Shannon, K., Hong, A., Ferguson, P., Jakrot, V., Gill, A., Scolyer, R., et al (2021). gd T cells in merkel cell carcinomas have a proinflammatory profile prognostic of patient survival. Cancer Immunology Research, 9(6), 612-623. [More Information]
• Ferguson, P., Kench, J., Watson, G. (2021). Intranuclear inclusions are a distinguishing morphological feature of renal cell carcinoma with leiomyomatous stroma. Pathology, 53(4), 543-545. [More Information]
• Paver, E., Cooper, W., Colebatch, A., Ferguson, P., Hill, S., Lum, T., Shin, J., O'Toole, S., Anderson, L., Scolyer, R., Gupta, R. (2021). Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation. Pathology, 53(2), 141-156. [More Information]
• Rabbie, R., Ferguson, P., Wong, K., Couturier, D., Moran, U., Turner, C., Emanuel, P., Haas, K., Saunus, J., Davidson, M., Shivalingam, B., Long, G., Scolyer, R., et al (2021). The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence. British Journal of Cancer, 124(1), 156-160. [More Information]
• Anderson, M., Ying, T., Wyburn, K., Ferguson, P., Strach, M., Grimison, P., Chadban, S., Gracey, D. (2021). Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report. BMC Urology, 21(1), 87. [More Information]

2020

• Gonzalez, M., Menzies, A., Pennington, T., Saw, R., Spillane, A., Stretch, J., Shannon, K., Ch'ng, S., Nieweg, O., Rojas, M., Lo, S., Scolyer, R., Long, G., et al (2020). A phase II study of neoadjuvant pembrolizumab and lenvatinib for resectable stage III melanoma: The neopele study. Journal of Clinical Oncology, 38(15), TPS10088. [More Information]
• Tetzlaff, M., Adhikari, C., Lo, S., Rawson, R., Amaria, R., Menzies, A., Wilmott, J., Ferguson, P., Ross, M., Spillane, A., Saw, R., Long, G., Scolyer, R., et al (2020). Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma. Annals of Oncology, 31(11), 1569-1579. [More Information]
• Scolyer, R., Rawson, R., Gershenwald, J., Ferguson, P., Prieto, V. (2020). Melanoma pathology reporting and staging. Modern Pathology, 33, 15-24. [More Information]
• Pruessmann, W., Rytlewski, J., Wilmott, J., Mihm Jr, M., Attrill, G., Dyring-Andersen, B., Fields, P., Zhan, Q., Colebatch, A., Ferguson, P., Thompson, J., Scolyer, R., et al (2020). Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence. Nature Cancer, 1(2), 197-209. [More Information]
• Jackett, L., Colebatch, A., Rawson, R., Ferguson, P., Thompson, J., McCarthy, S., Wilmott, J., Scolyer, R. (2020). Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy. The American Journal of Surgical Pathology, 44(3), 357-367. [More Information]
• Harris, C., Lo, S., Ahmed, T., Scolyer, R., Ferguson, P., Karim, R., Lam, T., Lee, K., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Saw, R. (2020). Primary dermal melanoma: clinical behaviour, prognosis and treatment. European Journal of Surgical Oncology, 46(11), 2131-2139. [More Information]
• Shklovskaya, E., Lee, J., Lim, S., Stewart, A., Pedersen, B., Ferguson, P., Saw, R., Thompson, J., Shivalingam, B., Carlino, M., Scolyer, R., Menzies, A., Long, G., Kefford, R., Rizos, H. (2020). Tumor mhc expression guides first-line immunotherapy selection in melanoma. Cancers, 12(11), 1-13. [More Information]
• Edwards, J., Ferguson, P., Lo, S., Da Silva, I., Colebatch, A., Lee, H., Saw, R., Thompson, J., Menzies, A., Long, G., Scolyer, R., Palendira, M., Wilmott, J., et al (2020). Tumor mutation burden and structural chromosomal aberrations are not associated with T-cell density or patient survival in acral, mucosal, and cutaneous melanomas. Cancer Immunology Research, 8(11), 1346-1353. [More Information]
• Grasso, C., Field, C., Tang, C., Ferguson, P., J Compton, B., Anderson, R., Painter, G., Weinkove, R., F Hermans, I., Berridge, M. (2020). Vaccines adjuvanted with an NKT cell agonist induce effective T-cell responses in models of CNS lymphoma. Immunotherapy, 12(6), 395-406. [More Information]
• Newell, F., Wilmott, J., Johansson, P., Nones, K., Addala, V., Mukhopadhyay, P., Broit, N., Amato, C., Van Gulick, R., Kazakoff, S., Saw, R., Spillane, A., Stretch, J., Rawson, R., Ferguson, P., Dodds, T., Thompson, J., Long, G., et al (2020). Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity. Nature Communications, 11(1), 1-14. [More Information]

2019

• Friedman, E., Dodds, T., Lo, S., Ferguson, P., Beck, M., Saw, R., Stretch, J., Lee, K., Nieweg, O., Spillane, A., Scolyer, R., Thompson, J. (2019). Correlation Between Surgical and Histologic Margins in Melanoma Wide Excision Specimens. Annals of Surgical Oncology, 26(1), 25-32. [More Information]
• Lee, H., Quek, C., Da Silva, I., Tasker, A., Batten, M., Rizos, H., Lim, S., Gide, T., Shang, P., Attrill, G., Madore, J., Edwards, J., Carlino, M., Guminski, A., Saw, R., Thompson, J., Ferguson, P., Palendira, M., Menzies, A., Long, G., Scolyer, R., Wilmott, J. (2019). Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients. OncoImmunology, 8(2), e1537581-1-e1537581-10. [More Information]
• Gide, T., Allanson, B., Menzies, A., Ferguson, P., Madore, J., Saw, R., Thompson, J., Long, G., Wilmott, J., Scolyer, R. (2019). Inter- and intra-patient heterogeneity of indoleamine 2,3-dioxygenase expression in primary and metastatic melanoma cells and the tumor microenvironment. Histopathology, 74(6), 817-828. [More Information]
• Rabbie, R., Ferguson, P., Molina-Aguilar, C., Adams, D., Robles-Espinoza, C. (2019). Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities. Journal of Pathology, 247(5), 539-551. [More Information]
• Colebatch, A., Ferguson, P., Newell, F., Kazakoff, S., Witkowski, T., Dobrovic, A., Johansson, P., Saw, R., Stretch, J., McArthur, G., Long, G., Thompson, J., Mann, G., Scolyer, R., Wilmott, J., et al (2019). Molecular Genomic Profiling of Melanocytic Nevi. Journal of Investigative Dermatology, 139(8), 1762-1768. [More Information]
• Long, G., Saw, R., Lo, S., Nieweg, O., Shannon, K., Gonzales, M., Guminski, A., Lee, J., Lee, H., Ferguson, P., Rawson, R., Wilmott, J., Thompson, J., Kefford, R., Ch'ng, S., Stretch, J., Rizos, H., Spillane, A., Scolyer, R., Menzies, A., et al (2019). Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial. The Lancet Oncology, 20(7), 961-971. [More Information]
• van Baar, M., Guminski, A., Ferguson, P., Martin, L. (2019). Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation. JAAD Case Reports, 5(6), 491-494. [More Information]
• Quek, C., Rawson, R., Ferguson, P., Shang, P., Da Silva, I., Saw, R., Shannon, K., Thompson, J., Hayward, N., Long, G., Mann, G., Scolyer, R., Wilmott, J. (2019). Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas. Oncotarget, 10(9), 930-941. [More Information]
• Hong, A., Ferguson, P., Dodds, T., Jones, D., Li, M., Yang, J., Scolyer, R. (2019). Significant association of PD-L1 expression with human papillomaviruspositivity and its prognostic impact in oropharyngeal cancer. Oral Oncology, 92, 33-39. [More Information]
• Wilmott, J., Johansson, P., Newell, F., Waddell, N., Ferguson, P., Quek, C., Patch, A., Nones, K., Shang, P., Pritchard, A., Saw, R., Spillane, A., Stretch, J., Shannon, K., Kefford, R., Menzies, A., Long, G., Thompson, J., Mann, G., Scolyer, R., et al (2019). Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility. International Journal of Cancer, 144(5), 1049-1060. [More Information]
• Newell, F., Kong, Y., Wilmott, J., Johansson, P., Ferguson, P., Cui, C., Li, Z., Kazakoff, S., Burke, H., Dodds, T., Tembe, V., Shang, P., Lo, S., Rawson, R., Long, G., Spillane, A., Shannon, K., Thompson, J., Saw, R., Mann, G., Scolyer, R., et al (2019). Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets. Nature Communications, 10(1), 1-15. [More Information]

2018

• Gallagher, S., Gunatilake, D., Beaumont, K., Sharp, D., Tiffen, J., Heinemann, A., Weninger, W., Haass, N., Wilmott, J., Madore, J., Ferguson, P., Rizos, H., Hersey, P. (2018). HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma. International Journal of Cancer, 142(9), 1926-1937. [More Information]
• Ferguson, P., Long, G., Scolyer, R., Thompson, J. (2018). Impact of genomics on the surgical management of melanoma. British Journal of Surgery, 105(2), e31-e47. [More Information]
• Cai, H., Cho, E., Li, Y., Sockler, J., Parish, C., Chong, B., Edwards, J., Dodds, T., Ferguson, P., Wilmott, J., Scolyer, R., Halliday, G., et al (2018). Melanoma protective antitumor immunity activated by catalytic DNA. Oncogene, 37(37), 5115-5126. [More Information]
• Ferguson, P., Gershenwald, J., Scolyer, R. (2018). Staging of Cutaneous Melanoma: Is There Room for Further Improvement? JAMA Network Open, 1(1), e180086. [More Information]
• Friedman, E., Ferguson, P., Thompson, J. (2018). When is surgery for metastatic melanoma still the most appropriate treatment option? Expert Review of Anticancer Therapy, 18(10), 943-945. [More Information]

2015

• Bouchery, T., Kyle, R., Camberis, M., Shepherd, A., Filbey, K., Smith, A., Harvie, M., Painter, G., Johnston, K., Ferguson, P., Jain, R., Roediger, B., Weninger, W., et al (2015). ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nature Communications, 6, 1-13. [More Information]